FilingIndex
8-KThe WireRed Alert

Executive Change

Filed Jan 2, 2024 · 2y ago · Accession 0001437749-24-000174

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): December 28, 2023     National Research Corporation (Exact name of registrant as specified in its charter)   Delaware 001-35929 47-0634000 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   1245 Q Street , Lincoln , Nebraska 68508 (Address of principal executive offices) (Zip Code)   ( 402 ) 475-2525 (Registrant's telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered $.001 Par Value Common Stock NRC The NASDAQ Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.       On December 28, 2023, Jona S. Raasch gave notice that she would no longer serve in the role of Chief Operating Officer of National Research Corporation, a Delaware corporation (the "Company"), effective December 31, 2023. Ms. Raasch will continue to serve in other roles as an employee of the Company. The Company thanks Ms. Raasch for over 30 years of dedicated leadership.         SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     NATIONAL RESEARCH CORPORATION   (Registrant)         Date: January 2, 2024 By: /s/ Kevin R. Karas     Kevin R. Karas     Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary
Filing details
Company
NRC HEALTH
Ticker
NRC
CIK
70487
Form type
8-K
Filing date
Jan 2, 2024
Report date
Dec 28, 2023
Document
nrc20240102_8k.htm
Size
149 KB